Scarica l'app Stockscreener
0.6775
2.65%
0.0175
Dopo l'orario di chiusura:
.66
-0.0175
-2.58%
Precedente Chiudi:
$0.66
Aprire:
$0.69
Volume 24 ore:
235.04K
Relative Volume:
0.13
Capitalizzazione di mercato:
$18.80M
Reddito:
-
Utile/perdita netta:
$-435.00K
Rapporto P/E:
-43.15
EPS:
-0.0157
Flusso di cassa netto:
$-665.30K
1 W Prestazione:
+2.57%
1M Prestazione:
-5.90%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.652
$0.7061
Intervallo di 1 settimana:
$0.6275
$0.8466
Portata 52W:
$0.561
$9.1796
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Nome
Curanex Pharmaceuticals Inc
Settore
Industria
Telefono
718-673-6078
Indirizzo
2 JERICHO PLAZA,, JERICHO
Confronta CURX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
0.6775 | 18.70M | 0 | -435.00K | -665.30K | -0.0157 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Curanex Pharmaceuticals Inc Borsa (CURX) Ultime notizie
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Curanex Pharmaceuticals IncCommon Stock (NQ: CURX - FinancialContent
Curanex Pharmaceuticals (CURX): An Emerging Force in US Botanical Drug Development - FinancialContent
Curanex Pharmaceuticals (CURX): An Emerging Force In US Botanical Drug Development - Menafn.com
Curanex engages Strategic Investor Relations to enhance Curanex’s visibility - TipRanks
Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement - The Manila Times
Curanex Pharmaceuticals Inc. Engages Strategic Investor - GlobeNewswire
Price performance - Yahoo
Curanex Pharmaceuticals Inc trading resumes - MSN
Curanex Pharmaceuticals Issues Shares Post-IPO - TipRanks
Curanex Pharmaceuticals issues shares in private placement and repays insider loans - Investing.com
Curanex Pharmaceuticals Inc’s Quiet Period To End on October 6th (NASDAQ:CURX) - Defense World
Curanex Pharmaceuticals Inc (CURX) company profile and facts - Yahoo! Finance UK
Day 5 of Loss Streak for Curanex Pharmaceuticals Stock with -89% Return (vs. 64% YTD) [9/23/2025] - Trefis
Jun Liu Net Worth (2025) - GuruFocus
RXRX Stock Surges: What’s Next? - StocksToTrade
CURX Pharmaceuticals: A New Dawn or a Passing Surge? - StocksToTrade
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Curanex Pharmaceuticals Inc trading halted, volatility trading pause - MSN
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.57% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.57% - Investing.com
Technical Analysis of Curanex Pharmaceuticals Inc (NASDAQ:CURX) - TradingView
Finance Watch: LB Pharmaceuticals Launches Second-Largest Biopharma IPO Of 2025 In The US - Citeline News & Insights
Chinese Stocks To Follow Now – September 11th - Defense World
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
Curanex Pharmaceuticals Boosts IPO Proceeds with Share Sale - TipRanks
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters - GlobeNewswire
$17.25M IPO Complete: Biotech Curanex Pharmaceuticals Secures Full Over-Allotment Exercise at $4/Share - Stock Titan
Curanex Pharmaceuticals Inc (CURX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Biopharma IPO activity slows, but 2025 returns are surging - BioWorld MedTech
Number of employees of Curanex Pharmaceuticals Inc – BOATS:CURX - TradingView
Curanex Pharmaceuticals Inc Financial Statements – NASDAQ:CURX - TradingView
Finance Watch: Ever The Outlier, Biotech Outpaces Broader Stocks - insights.citeline.com
Curanex Pharmaceuticals Inc Azioni (CURX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):